J. Newellprice et al., A COMBINED TEST USING DESMOPRESSIN AND CORTICOTROPIN-RELEASING HORMONE IN THE DIFFERENTIAL-DIAGNOSIS OF CUSHINGS-SYNDROME, The Journal of clinical endocrinology and metabolism, 82(1), 1997, pp. 176-181
To assess the ability of desmopressin to differentiate between pituita
ry and ectopic ACTH-dependent Cushing's syndrome and to determine whet
her diagnostic accuracy could he improved by administering it together
with human sequence CRH, we examined its effects on cortisol and ACTH
secretion when given alone or in combination with CRH in patients wit
h Cushing's syndrome of Oi varied etiology and compared these data to
the results of a standard CRH test in the same individuals. Each patie
nt was studied on three occasions, in random order, separated by at le
ast 48 h. At 0900 h, via an indwelling forearm cannula, 10 mu g desmop
ressin, 100 mu g CRH, or a combination of the two were given as an iv
bolus; thereafter, blood was drawn every 15 min for 2 h. The responses
to the individual agents were determined according to the timing and
calculation criteria suggested by Nieman et al. (1993). A total of 25
patients with Gushing's syndrome were studied: 17 patients with pituit
ary-dependent Cushin's syndrome, Gushing's disease (CD); 6 patients wi
th occult ectopic ACTH secretion (EC): and 3 patients with primary adr
enal (ACTH-independent) Cushin's syndrome. In this series, the best di
scrimination among ACTH-dependent patient groups was achieved using th
e combined test. Using the responses of plasma cortisol. all 17 patien
ts with CD showed a rise greater than any of the 5 patients with EC, w
hereas 1 patient with CD showed a plasma ACTH response within the rang
e seen in the patients with EC. Plasma cortisol responses to desmopres
sin alone were seen in 14 of 17 patients with CD and 1 of 5 patients w
ith EC and, after CBH alone, in 15 of 17 patients with CD but in no pa
tient with EC. In contrast, plasma ACTH responses after CRH alone were
seen in 14 of 17 patients with CD and 2 of 5 patients with EC and, af
ter desmopressin alone, in 12 or 17 with CD and 3 of 5 with EC, thus i
ndicating overlapping responses between the groups and poorer discrimi
nation. No responses were seen in the ACTH-independent group.These dat
a indicate that desmopressin causes the secretion of ACTH and cortisol
in patients with ACTH-dependent Gushing's syndrome, and that in combi
nation with CBH, it may provide an improvement over the standard CRH t
est in the differential diagnosis of ACTH-dependent Cushing's syndrome
. Furthermore, these data suggest that there may be abnormalities in v
asopressin receptor function or number in ACTH-secreting tumors.